GOLDMAN SACHS GROUP INC - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 35 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$41,000
+32.3%
39,326
+51.4%
0.00%
Q2 2021$31,000
-64.0%
25,976
+11.2%
0.00%
Q4 2020$86,000
+95.5%
23,360
+53.3%
0.00%
Q3 2019$44,000
+4.8%
15,242
-3.2%
0.00%
Q2 2019$42,000
-90.5%
15,748
-68.3%
0.00%
Q3 2018$442,00049,6590.00%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 56,250$19,6881.50%
HOLLENCREST CAPITAL MANAGEMENT 129,000$45,1500.01%
CREDIT AGRICOLE S A 200,000$70,0000.00%
ROPES WEALTH ADVISORS LLC 10,217$3,5760.00%
UBS Group AG 67,174$23,5100.00%
JOHNSON INVESTMENT COUNSEL INC 42,128$14,7450.00%
OSAIC HOLDINGS, INC. 30$00.00%
Parallel Advisors, LLC 1,000$3500.00%
WADE G W & INC 35,000$120.00%
GEODE CAPITAL MANAGEMENT, LLC 396,871$1380.00%
View complete list of IDERA PHARMACEUTICALS INC shareholders